PL401911A1 - Zastosowanie preparatu o wlasciwosciach immunoregulatorowych - Google Patents

Zastosowanie preparatu o wlasciwosciach immunoregulatorowych

Info

Publication number
PL401911A1
PL401911A1 PL401911A PL40191112A PL401911A1 PL 401911 A1 PL401911 A1 PL 401911A1 PL 401911 A PL401911 A PL 401911A PL 40191112 A PL40191112 A PL 40191112A PL 401911 A1 PL401911 A1 PL 401911A1
Authority
PL
Poland
Prior art keywords
preparation
immunoregulatory properties
immunoregulatory
therapy
disorders
Prior art date
Application number
PL401911A
Other languages
English (en)
Other versions
PL217193B1 (pl
Inventor
Marta Jakubik
Joanna Rymaszewska
Antoni Polanowski
Tadeusz Trziszka
Original Assignee
Uniwersytet Przyrodniczy We Wroclawiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy We Wroclawiu filed Critical Uniwersytet Przyrodniczy We Wroclawiu
Priority to PL401911A priority Critical patent/PL217193B1/pl
Publication of PL401911A1 publication Critical patent/PL401911A1/pl
Publication of PL217193B1 publication Critical patent/PL217193B1/pl

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Wynalazek dotyczy zastosowania preparatu immunoregulatorowego pozyskanego z zóltka jaja do wytwarzania srodka farmaceutycznego, zwlaszcza suplementu diety, do stosowania w profilaktyce zaburzen funkcji poznawczych o róznym podlozu i/lub wspomagajaco w terapii tych zaburzen, zwlaszcza u chorych z niezadowalajaca odpowiedzia na konwencjonalna terapie.
PL401911A 2012-12-05 2012-12-05 Zastosowanie preparatu o właściwościach immunoregulatorowych PL217193B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL401911A PL217193B1 (pl) 2012-12-05 2012-12-05 Zastosowanie preparatu o właściwościach immunoregulatorowych

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL401911A PL217193B1 (pl) 2012-12-05 2012-12-05 Zastosowanie preparatu o właściwościach immunoregulatorowych

Publications (2)

Publication Number Publication Date
PL401911A1 true PL401911A1 (pl) 2013-08-19
PL217193B1 PL217193B1 (pl) 2014-06-30

Family

ID=48951787

Family Applications (1)

Application Number Title Priority Date Filing Date
PL401911A PL217193B1 (pl) 2012-12-05 2012-12-05 Zastosowanie preparatu o właściwościach immunoregulatorowych

Country Status (1)

Country Link
PL (1) PL217193B1 (pl)

Also Published As

Publication number Publication date
PL217193B1 (pl) 2014-06-30

Similar Documents

Publication Publication Date Title
TN2015000278A1 (en) Autotaxin inhibitors
PH12013502240B1 (en) Novel compounds as modulators of protein kinase
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
IL236221A (en) History of theophyridone and pharmacological preparations containing them for the treatment of diseases
MX343687B (es) Compuestos sulfonamida tricíclica y métodos para su fabricación y uso.
WO2014176128A3 (en) Compositions and methods for the therapy and diagnosis of influenza
HK1207306A1 (en) Modified polynucleotides for the production of proteins associated with human disease
NZ702977A (en) 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
EP4324527A3 (en) Formulations of enzalutamide
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
MX343688B (es) Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
MX2014008706A (es) Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
MX2015016741A (es) Inhibidores de pi3 cinasa delta y gama selectivos duales.
EP4414376A3 (en) Novel depsipeptide and uses thereof
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
GT201400161A (es) Fenilimidazopirazoles sustituidos y su uso
TN2016000107A1 (en) Substituted phenylalanine derivatives
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
BR112015011759A2 (pt) composição simbiótica e uso da mesma
EA201491426A1 (ru) Новые фармацевтические композиции, содержащие фосфатидилсерин и куркумин
BR112015005268A2 (pt) seringa contendo uma composição, em particular farmacêutica, composta por imunoglobulinas, seu método de fabricação e respectivo uso
MX362854B (es) Siarn y su uso en los metodos y composiciones para el tratamiento y/o prevencion de enfermedades de los ojos.
AU358081S (en) Biscuit